Benitec Biopharma Analyst Ratings
Benitec Biopharma Analyst Ratings
While ratings are subjective and will change, the latest Benitec Biopharma (BNTC) rating was a maintained with a price target of $4.00 to $6.00. The current price Benitec Biopharma (BNTC) is trading at is $3.15, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/26/2023 | 90.48% | JMP Securities | $4 → $6 | Maintains | Market Outperform |
| 06/26/2023 | 26.98% | JMP Securities | → $4 | Reiterates | Market Outperform → Market Outperform |
| 05/18/2023 | 26.98% | JMP Securities | $4 → $4 | Reiterates | Market Outperform → Market Outperform |
| 10/18/2022 | 26.98% | JMP Securities | → $4 | Initiates Coverage On | → Market Outperform |
| 09/23/2022 | 26.98% | HC Wainwright & Co. | $10 → $4 | Maintains | Buy |
| 02/17/2022 | 217.46% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 10/05/2020 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 09/26/2023 | 90.48% | JMP 证券 | 4 美元 → 6 美元 | 维护 | 市场表现跑赢大盘 |
| 06/26/2023 | 26.98% | JMP 证券 | → 4 美元 | 重申 | 市场跑赢大盘 → 市场跑赢大盘 |
| 05/18/2023 | 26.98% | JMP 证券 | 4 美元 → 4 美元 | 重申 | 市场跑赢大盘 → 市场跑赢大盘 |
| 2022 年 10 月 18 日 | 26.98% | JMP 证券 | → 4 美元 | 启动覆盖范围开启 | → 市场跑赢大盘 |
| 09/23/2022 | 26.98% | HC Wainwright & Co. | 10 美元 → 4 美元 | 维护 | 买 |
| 02/17/2022 | 217.46% | HC Wainwright & Co. | → 10 美元 | 启动覆盖范围开启 | → 购买 |
| 2020 年 5 月 10 日 | — | 拉登堡塔尔曼 | 降级 | 买入 → 中性 |
What is the target price for Benitec Biopharma (BNTC)?
贝尼特克生物制药（BNTC）的目标价格是多少？
The latest price target for Benitec Biopharma (NASDAQ: BNTC) was reported by JMP Securities on September 26, 2023. The analyst firm set a price target for $6.00 expecting BNTC to rise to within 12 months (a possible 90.48% upside). 4 analyst firms have reported ratings in the last year.
JMP Securities于2023年9月26日公布了贝尼特克生物制药（纳斯达克股票代码：BNTC）的最新目标股价。该分析公司将目标股价定为6.00美元，预计BNTC将在12个月内上涨至90.48％（可能上涨90.48％）。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Benitec Biopharma (BNTC)?
贝尼特克生物制药（BNTC）的最新分析师评级是多少？
The latest analyst rating for Benitec Biopharma (NASDAQ: BNTC) was provided by JMP Securities, and Benitec Biopharma maintained their market outperform rating.
Benitec Biopharma（纳斯达克股票代码：BNTC）的最新分析师评级由JMP Securities提供，Benitec Biopharma维持其市场跑赢大盘评级。
When is the next analyst rating going to be posted or updated for Benitec Biopharma (BNTC)?
Benitec Biopharma（BNTC）的下一份分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Benitec Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Benitec Biopharma was filed on September 26, 2023 so you should expect the next rating to be made available sometime around September 26, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表，与贝尼泰克生物制药公司的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Benitec Biopharma的最新评级是在2023年9月26日提交的，因此你应该预计下一个评级将在2024年9月26日左右公布。
Is the Analyst Rating Benitec Biopharma (BNTC) correct?
Benitec Biopharma（BNTC）的分析师评级是否正确？
While ratings are subjective and will change, the latest Benitec Biopharma (BNTC) rating was a maintained with a price target of $4.00 to $6.00. The current price Benitec Biopharma (BNTC) is trading at is $3.15, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但贝尼特克生物制药（BNTC）的最新评级保持不变，目标股价为4.00美元至6.00美元。Benitec Biopharma（BNTC）目前的交易价格为3.15美元，超出了分析师的预测区间。
